跳至主要内容
临床试验/NCT02762214
NCT02762214Unknown3 期

Role Of Uterine Manipulator in Hysterectomy for Early Stage Endometrial Cancer

Catholic University of the Sacred Heart2 个研究点 分布在 1 个国家目标入组 154 人开始时间: 2015年10月最近更新:
适应症

试验速览

阶段
3 期
入组人数
154
试验地点
2
主要终点
Upstaging rate

研究概览

简要总结

Prospective multicentric randomized trial to evaluate the role of uterine manipulator on laparoscopic/robotic total hysterectomy for the treatment of early stage G1 - G2 endometrial cancer (International Federation of Gynecology and Obstetrics - FIGO stages IA-IB).

详细描述

This multicentric prospective randomized Phase III trial is aimed to verify if the use of uterine manipulator for laparoscopic/robotic treatment of early stage endometrial cancer can influence the impact of peritoneal cytology and lymph vascular space invasion (LVSI) and the outcomes in terms of perioperative and oncological (disease free survival - DFS, overall survival - OS) outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • For patients
  • Age > 18 < 80 years
  • Patient's informed consent
  • American Society of Anesthesiologists: < class III or IV
  • No actual pregnancies
  • Body Mass Index (BMI) ≤ 35
  • For diseases
  • Early stage endometrial cancer (IA-IB)
  • Endometrioid histotype (G1-G2)

排除标准

  • For patients
  • Age > 18 < 80
  • Actual pregnancies
  • Previous gynecological cancer
  • For disease
  • Type II endometrial cancer histotype
  • Grade 3 endometrial cancer
  • Advanced stage endometrial cancer (II - IV)
  • Previous radiotherapy on the pelvic field
  • Uterine size larger than conform 12 weeks gestation or 9 cm in horizontal
  • Necessity of laparotomic procedures

结局指标

主要结局

Upstaging rate

时间窗: 30 days

Evaluation of Lymphovascular space invasion and pre- / post-Hysterectomy pelvic cytology in order to investigate if the use of uterine manipulator has a role in upstaging of early-stage endometrial cancer

次要结局

  • Blood Loss(Intraoperative)
  • Complications(within 30 days from surgery)
  • Impact on postoperative pain(Postoperative)
  • Impact of surgical procedure(Perioperative)
  • Role of uterine manipulator in Obesity(Intraoperative)
  • Oncological Outcomes: Rate of local relapses(1 years - 5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Giovanni Scambia

Professor

Catholic University of the Sacred Heart

研究点 (2)

Loading locations...

相似试验